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Abstract
Background: Achalasia is a well-characterized esophageal motor disorder but the rarity of the
disease limits performing large studies on its demographic and clinical features.
Methods: Prospectively, 213 achalasia patients (110 men and 103 women) were enrolled in the
study. The diagnosis established by clinical, radiographic, and endoscopic as well as manometry
criteria. All patients underwent a pre-designed clinical evaluation before and within 6 months after
the treatment.
Results: Solid dysphagia was the most common clinical symptom in men and women. Chest pain
was the only symptom which was significantly different between two groups and was more
complained by women than men (70.9% vs. 54.5% P value= 0.03). Although the occurrence of chest
pain significantly reduced after treatment in both groups (P < 0.001), it was still higher among
women (32% vs. 20.9% P value= 0.04). In both sexes, chest pain did not relate to the symptom
duration, LES pressure and type of treatment patients received. Also no significant relation was
found between chest pain and other symptoms expressed by men and women before and after
treatment. Chest pain was less frequently reported by patients over 56 yrs of age in comparison
to those less than 56 yrs (p < 0.05).
Conclusion: It seems that chest pain is the distinct symptom of achalasia which is affected by sex
as well as age and does not relate to the duration of illness, LESP and the type of treatment achalasia
patients receive.
Background
Achalasia is a primary esophageal motor disorder of
unknown etiology characterized by absent esophageal
peristalsis and abnormal lower esophageal sphincter
(LES) relaxation [1-3]. The disease can occur at any age
but it is usually diagnosed in patients who are between 25
and 60 years. The motor abnormalities found in this dis-
ease compromise the normal esophageal emptying and
result in several clinical symptoms including dysphagia as
the most common symptom, postprandial and/or noctur-
nal regurgitation, weight loss, chest pain and cough [4-7].
Men and women are affected with equal frequencies [8],
but data regarding the characteristics differences between
males and females in achalasia is spars.
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Although studies on esophageal motility in normal indi-
viduals have shown some differences between males and
females [9], this was not widely studied among achalasia
patients. Demographic studies in achalasia have been
hampered by low incidence and rarity of the disease,
which limits the number of cases to be studied and there-
fore weakens the probability to find significant differences
in subgroups of achalasia patients.
Our center as the major referral center for achalasia in Iran
provides us with the opportunity to include relatively
large number of patients during these years. In this study,
we aimed to evaluate the differences of the clinical fea-
tures between men and women before and after treat-
ment, and assess whether the dissimilarities are related to
the clinical course, demographic features, or manometric
characteristics, and determine how treatment affects the
discrepancies.
Methods
Patients
Over a period of ten years from July 1994 to December
2004 all symptomatic patients with idiopathic achalasia
referred to the Shariati Hospital of Tehran University of
Medical Sciences were consecutively enrolled in the study.
The diagnosis of achalasia was established by clinical
(dysphagia, regurgitation, chest pain), radiographic
(bird's beak appearance of the lower esophageal sphinc-
ter, decreased esophageal peristalsis, delayed esophageal
emptying) and endoscopic as well as manometric criteria
(aperistalsis of the esophageal body, increased lower
esophageal sphincter pressure and incomplete relaxation
(<50%) on swallowing).
The study protocol was reviewed and approved by the
ethic committee of digestive disease research center of
Tehran University of Medical Sciences and informed con-
sent was obtained from all patients.
Clinical evaluations
A structured interview evaluating demographic as well as
clinical features was conducted at the time of their first
visit and within 6 months following their initial treatment
(before the second treatment following relapse), and the
standard questionnaire was filled for each of the patients.
Evaluation of their clinical features was done on the bases
of five clinical symptoms; solid and liquid dysphagia,
active and passive regurgitation and chest pain. The fre-
quency of each of these symptoms was scored on a scale
of 0–3 to obtain the total symptomatic score, as described
elsewhere [10,11] (table 1). The highest obtainable score
was 15.
Additionally the history of other symptoms such as noc-
turnal cough, weight loss as well as any evidence of the
previous treatment was taken.
The patients underwent botulinum toxin injection or
pneumatic dilation as described bellow.
Subsequently the total symptomatic score was compared
among men and women patients before and within 6
months after the treatment.
Esophageal manometry
Manometric assessment was added to achalasia patient's
evaluation from 1997 in our center. After an overnight
fast, manometry was carried out by a standard eight chan-
nel low compliance catheter (Synecticw, Synectics, Stock-
holm, Sweden) perfused with hydraulic pump. Lower
esophageal sphincter pressure (LESP) was studied by
rapid pull through (RPT) technique in deep expiration.
The average of five RPT analyses was recorded as resting
LESP. An average of 10 water swallows was used to assess
body contraction waves and LES relaxation.
Botulinm toxin injection
Botulinum toxin injection (BT) was offered as the thera-
peutic choice in achalasia patients with tortuous meg-
aesophagus, epiphrenic diverticula, previous
cardiomyotomy, age > 60 yrs with cardiopulmonary or
comorbid diseases. Four-hundred units of Dysport (Ipsen,
UK) equal to 160 units of Botox [12] was injected follow-
ing an overnight fast, using 100 units in each quadrant at
the level of LES under videoendoscopic guide.
Table 1: Scoring system for evaluation of clinical symptoms
S c o r e 0123
Symptoms
Dysphagia to solids none weekly Daily each meal
Dysphagia to liquids none weekly Daily each meal
Active regurgitation none weekly Daily each meal
Passive regurgitation none monthly Weekly daily
Chest pain none monthly Weekly dailyBMC Gastroenterology 2006, 6:12 http://www.biomedcentral.com/1471-230X/6/12
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Pneumatic dilatation
After a clear liquid diet for 12 h and an overnight fast,
pneumatic dilatations (PD) were performed using 35 or
30 mm Rigiflex balloon (The technique changed from
using 35 mm balloon diameter to 30 mm diameter Since
1997) under a conscious sedation with diazepam and
meperidin (5–10 and 25–50 mg I.V respectively). Follow-
ing a complete upper gastrointestinal endoscopy, balloon
dilators were passed over a guide wire and were posi-
tioned such that LES places at the midpoint of the balloon
under videoendoscopic guide. Rigiflex balloons were
gradually inflated up to 10 psi in 30s and maintained for
another 60 s. After emptying and pulling out the balloons,
patients were endoscoped again to assess the LES opening
(relaxation) and any evidence of bleeding or perforation
and were discharged after a 6 h observation if remained
asymptomatic.
Statistical analysis
Continuous variables were summarized as mean ± stand-
ard deviation. Qualitative variables were summarized as a
percentage of the group total. Comparing numerical vari-
ables with assumed equal variances and different vari-
ances tested by t student and mann-withney respectively.
A p-value of less than 0.05 was considered significant.
Results
213 patients including 110 (51.6%) men and 103
(48.4%) women were enrolled in the study. No signifi-
cant differences were found in the characteristics of men
and women before their initial treatment (table 2).
The frequencies of the clinical symptoms were compared
between men and women before and within 6 months of
treatment.
Before treatment
Solid dysphagia was noted as the first clinical symptom in
the disease course in 81% of men and 76.4% of women.
No significant difference was found in the clinical features
of achalasia between two groups except for the chest pain
which was more common in women than in men (70.9%
vs. 54.5% P = 0.03) (table 3).
LESP was measured in 103 patients (50 women and 53
men), Mean LESP was 53.7 ± 17.4 and 58.6 ± 19.5 mmHg
in men and women respectively (P = 0.1). The LESP did
not differ significantly between patients with and without
chest pain, neither in men nor in women (P = 0.6 & 0.8
respectively).
Out of 110 men and 103 women, 47.3% vs. 54.4% had
received no previous treatment, 3.6% vs. 10.6% had
undergone surgical myotomy, 47.3% vs. 30.2% had been
recommended to use medications such as nitrates or cal-
cium channel blockers, 0.9% vs. 1.9% and 0.9% vs. 2.9%
had undergone previous PD and BT respectively.
Table 3: Comparing the presenting symptoms between men and women before therapy
Variable Women (n = 103, 48.4%) Men (n = 110, 51.6%) P Value
Mean pre treatment total score (SD) 9.9 (2.7) 9 (3.1) 0.01
Pre treatment Solid dysphagia 100% 96.4% NS (0.2)
Pre treatment Liquid dysphagia 98.1% 90.9% NS (0.5)
Pre treatment active regurgitation 71.8% 73.6% NS (0.2)
Pre treatment passive regurgitation 77.7% 63.6% NS (0.2)
Pre treatment chest pain Daily 12.6% 70.9% 8.2% 54.5% 0.03
Weekly 44.7% 38.2%
Monthly 13.6% 8.1%
Never 29.1% 45.5%
Nocturnal cough 51.5% 40% NS (0.09)
NS: Not Significant
Table 2: Comparing the characteristics between men and women before the initial treatment
Variable Women (n = 103, 48.4%) Men (n = 110, 51.6%) P Value
Age (SD) (min-max) 39.3 (14.5) (16–77 y) 37.7 (14.1) (14–75 y) NS* (0.4)
Mean symptom duration (min-max) (Years) 4.8 (0.5–28) 4.6 (0.4–30) NS (0.9)
Mean weight loss (Kg) (SD) 3.2 (4) 3.2 (4.9) NS (0.7)
NS: Not SignificantBMC Gastroenterology 2006, 6:12 http://www.biomedcentral.com/1471-230X/6/12
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The frequency of chest pain experienced by men and
women had no significant relationship with the type of
pretreatment therapy they had received (P values > 0.05).
Occurrence of chest pain did not relate to the sympto-
matic duration before treatment in both sexes; mean
symptom duration in women with (n = 73) and without
chest pain (n = 30) was 4.5 ± 3.6 and 5.5 ± 6.2 yrs respec-
tively (P = 0.3), while 4.5 ± 4.7 and 4.7 ± 6.4 yrs in 60 men
with and 50 men without chest pain (P = 0.8).
No significant relation was found between chest pain and
other symptoms such as solid dysphagia, liquid dys-
phagia, active and passive regurgitation (P > 0.05 in all
cases).
Chest pain was less frequently reported by patients over
56 yrs of age in comparison to those less than 56 yrs
(42.8% vs. 65.5% P = 0.02).
After treatment
In total, 171 (80.5%) patients underwent pneumatic dila-
tation and 42 (19.5%) underwent botulinum toxin injec-
tion; 62.4% and18.8 % of patients underwent one and
two sessions of PD, and 12.2% and 5.6% of the cases
received one and two BT injections respectively.
Symptoms of the patients were evaluated again at 6
months after treatment, as depicted in table 4. Frequency
of chest pain after treatment did not relate to the type of
therapy that achalasia patients received (P = 0.4). There
was no significant relation between chest pain and other
symptoms such as solid dysphagia, liquid dysphagia,
active and passive regurgitation (all P values > 0.05).
The occurrence of chest pain significantly reduced after
treatment in both sexes (P = 0.0001) but it was still higher
among women (32% vs. 20.9% P = 0.04).
During 6 months after treatment, the occurrence of chest
pain in patients over 56 was significantly lower in com-
parison to younger group; 7.1% vs. 29.2% P = 0.01
Discussion
We evaluated the clinical features of achalasia in relation
to the demographic aspects of the affected individuals,
studying the consecutively enrolled achalasia patients in
our center. Potential epidemiological limitations of stud-
ies on rare diseases as achalasia include inadequate sam-
ple size and the consequent selective presentation of
results due to multiple comparisons. Regarding to these
concerns, we avoided multilayer comparisons and tried to
limit the number of comparisons in order to be supported
by our sample size. We have tried to evaluate the clinical
profile of our patients in detail, but more extensive ques-
tionnaire could be more informative in term of finding
differences between men and women.
It has been suggested that gender and age affect the clini-
cal presentation of achalasia [13-15]. A study by d' Altero-
che et al. showed that chest pain was 1.7 times more
frequent in women than in men, but no explanation was
suggested by the authors [14].
In the present study, we found chest pain is the only
symptom that differs between men and women; it is more
common in women before or after treatment. The occur-
rence of chest pain did not relate to the LESP in both sexes.
Some previous studies have tried to figure out the under-
lying causes of chest pain in achalasia patients. Eckardt et
al evaluated achalasia patients with and without com-
plaining chest pain and found that the occurrence of this
symptom was unrelated to LESP. In addition, They
showed that repetitive esophageal contractions were more
common in patients experiencing chest pain, although
this finding barely reached the specific cut off [16].
Another study found that 38% of patients with reappear-
ance of peristalsis waves in manometry performed 1 year
after dilation experienced the symptom of chest pain,
while only 6% of those with esophageal aperistalsis com-
plained about this symptom. In addition, post dilation
peristalsis was strongly correlated to higher contraction
waves amplitude before treatment [6].
Results of Dantas et al. study on normal subjects could
help to explain the observed difference in frequency of
chest pain between men and women in our series. They
performed manometry on 20 men and 20 women with
the same age distribution. There was no difference in LESP
between men and women, but a higher duration of con-
tractions 5 cm above the LES was observed in women
(women: 4.5 ± 0.3s men: 3.7 ± 0.2s p < 0.05). On the
other hand no gender difference in esophageal functional
anatomy or innervations has been described [9].
All these data suggest that higher occurrence of chest pain
among women may be interrelated to higher amounts or
amplitude of contractions in this group.
In addition, women are more likely to experience recur-
rent pains or report more intense and longer duration
pain comparing to men [17,18]. This might be due to
some biological and psychological differences between
these two groups which can lead to lower pain tolerance
and threshold in women [18]. Thus the different pain
expression in women could also play a role in the differ-
ence seen in the chest pain between two genders in acha-
lasia.BMC Gastroenterology 2006, 6:12 http://www.biomedcentral.com/1471-230X/6/12
Page 5 of 6
(page number not for citation purposes)
We found that chest pain is conversely related to the age
and is less frequent in elderly.
Previous studies also pointed that chest pain decreases sig-
nificantly with ageing [14,16].
Clouse and Simmons reported that not only chest pain is
less frequent in elderly subjects but also the pain is less
sever in this age group[13,19]. It has been shown that
there is no difference in LESP and other manometric fea-
tures in older comparing younger achalasia patients
except the lower LES residual pressure in elderly [13,20].
The lower LES residual pressure along with lesser visceral
perception in elderly were considered to explain lesser
expression of chest pain in the older achalasia patients
[16].
In agreement with previous studies, our results showed
that the occurrence and intensity of chest pain was unre-
lated to the intensity of other esophageal symptoms [16].
This was the case in both sexes, either before or after treat-
ment.
There was no significant relationship between symptom
duration and chest pain in our study. Rakita et al. and
Alteroche et al. also found that duration of symptoms had
little impact on premyotomy symptom frequency [14,15].
However, results of the other study showed that patients
with chest pain had a shorter duration of symptoms
before the diagnosis of achalasia. The authors suggested
that more pronounced disease in patients with chest pain
could call for sooner investigation to receive a diagnosis at
an earlier stage [16].
Some studies have indicated that a successful treatment
improves chest pain but rarely makes this symptom abol-
ish [1,16,21,22]. We found that occurrence of chest pain
decreased after therapeutic session in both sexes, but
remained still higher among women. The occurrence of
other symptoms was not different between men and
women after therapy. This shows that not only chest pain
is more frequent in women but also responds less favora-
ble to the current treatments. It has been previously sug-
gested that these patients could also benefit from
accompanying behavioral and emotional treatments to
reduce their pain [22,23]. Although around 70% of
patients in our study reported some extent of solid dys-
phagia after therapy, the total dysphagia score has signifi-
cantly decreased after treatment and only in 18% of
patients the dysphagia score was greater than 1.
Many efforts have been done in treatment of achalasia
during the past decade, but the affected patients still suffer
from chest pain even after otherwise successful treatment.
Timed barium swallow as an objective means of assessing
esophageal emptying would show whether the continued
chest pain in achalasia patients after treatment is associ-
ated with unfavorable esophageal emptying. Studies to
clarify the underlying mechanism of this symptom would
help us to perform more efficient managements for acha-
lasia.
Conclusion
It seems that chest pain is the only symptom of achalasia
which is affected by sex as well as age. The duration of ill-
ness, lower esophageal sphincter pressure and the type of
therapeutic procedure do not relate to the occurrence of
chest pain in achalasia and can not explain its higher
occurrence in women. The relation between chest pain
and sex, observed in this study needs to be explored in
detail to understand the physiologic- based content of this
symptom in achalasia.
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